Eidos Therapeutics, Inc. (EIDX)
(Delayed Data from NSDQ)
$25.98 USD
+1.19 (4.80%)
Updated May 3, 2019 04:00 PM ET
After-Market: $25.98 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
[EIDX]
Reports for Purchase
Showing records 1 - 20 ( 55 total )
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Yas'' Weekly Recap of Our Key Notes and 8 Doc Calls Upcoming in 1H20
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
4Q19 - Sequence of 2020 Events - Stock Reaction
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
As we are three weeks away from JPM Healthcare conference.
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Can''t Miss AG10 OLE Takeaways from Our Expert Call with Dr. Keyur Shah
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
OLE Data Looks Much Prettier than Expected by the Street
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
Healthcare-Live From AHA: A Thrilling Day For ATTR-CM
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
Get a Head Start on AHA in Philadelphia with Our Prep Material
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
Industry: Medical - Biomedical and Genetics
Healthcare - Earnings Recap: Halftime Show of Our Most In-Depth, Differentiated Earnings Yet
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
Get to the Heart of AG10?s OLE Data in ATTR-CM - Join our Nov. 20 Call
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
3Q19 - Smooth Sailing Ahead for ATTRCM Enrollment
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y
Industry: Medical - Biomedical and Genetics
Trick or Treat ahead of AHA: Treat With Our Day-by Day Calendar
Provider: Roth Capital Partners, Inc.
Analyst: RAHIMI Y